Vimarsana
Biggest News Aggregation in the World

Treatment Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Treatment Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Treatment Study Today - Breaking & Trending Today

Attention deficit/hyperactivity disorder (ADHD) in children: more focus on care and support, less on diagnosis - Vimarsana News

Attention deficit/hyperactivity disorder (ADHD) in children: more focus on care and support, less on diagnosis

ADHD diagnoses continue to increase, but Luise Kazda and colleagues argue that the push for diagnosis could be hampering access to care and support for children ### Key messages The prevalence of attention deficit/hyperactivity disorder (ADHD) in children has been rising for several decades,1234 including in countries with previously low rates.5 In Germany, for example, the prevalence of ADHD in children rose by 77% over 10 years, from 2.2% in 2004 to 3.8% in 2013.6 Enhanced awareness of mental wellbeing and neurodiversity during the covid-19 pandemic has led to a change in public discourse ar...

Source: bmj.com
Cardiovascular Disease Risk of Long-Term ADHD Medication Use - Vimarsana News

Cardiovascular Disease Risk of Long-Term ADHD Medication Use

Cardiovascular disease risk may increase alongside long-term ADHD medication use, according to a new observational study. ADHD experts say the benefits of medication outweigh the risks.

What would actually cut homelessness and overdose risk? - Vimarsana News

What would actually cut homelessness and overdose risk?

Interviews with unhoused people who've recently experienced opioid overdose indicate ways to approach places like "Mass and Cass" in Boston.

Benitec Biopharma Inc.: Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update - Vimarsana News

Benitec Biopharma Inc.: Benitec Biopharma Releases Second Quarter 2023 Financial Results and Provides Operational Update

HAYWARD, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) ("Benitec" or "Company"), a development-stage, gene therapy-focused, biotechnology company developing novel genetic

Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update - Vimarsana News

Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com